State Street Corp Allovir, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Allovir, Inc. stock. As of the latest transaction made, State Street Corp holds 222,439 shares of ALVR stock, worth $124,565. This represents 0.0% of its overall portfolio holdings.

Number of Shares

222,439

Previous 222,439 -0.0%

Holding current value

$124,565

Previous $160,000 12.5%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.72 - $0.82 $688,188 - $783,769	-955,817 Reduced 81.12%	222,439 $160,000
Q1 2024 May 15, 2024	BUY	$0.64 - $0.78 $62,177 - $75,778	97,152 Added 8.99%	1,178,256 $895,000
Q4 2023 Feb 14, 2024	SELL	$0.68 - $2.39 $7,407 - $26,036	-10,894 Reduced 1.0%	1,081,104 $735,000
Q3 2023 Nov 14, 2023	BUY	$2.15 - $3.64 $339,768 - $575,236	158,032 Added 16.92%	1,091,998 $2.35 Million
Q2 2023 Aug 14, 2023	BUY	$3.17 - $5.82 $153,301 - $281,455	48,360 Added 5.46%	933,966 $3.18 Million
Q1 2023 May 15, 2023	BUY	$3.94 - $7.05 $22,434 - $40,142	5,694 Added 0.65%	885,606 $3.49 Million
Q4 2022 Feb 14, 2023	BUY	$4.7 - $9.98 $11,331 - $24,061	2,411 Added 0.27%	879,912 $4.51 Million
Q3 2022 Nov 15, 2022	BUY	$4.13 - $8.79 $649,649 - $1.38 Million	157,300 Added 21.84%	877,501 $6.92 Million
Q2 2022 Aug 15, 2022	BUY	$3.26 - $7.06 $472,771 - $1.02 Million	145,022 Added 25.21%	720,201 $2.81 Million
Q1 2022 May 16, 2022	SELL	$6.75 - $13.52 $4.37 Million - $8.76 Million	-647,916 Reduced 52.97%	575,179 $3.88 Million
Q4 2021 Feb 14, 2022	BUY	$12.94 - $25.99 $93,931 - $188,661	7,259 Added 0.6%	1,223,095 $15.8 Million
Q3 2021 Nov 15, 2021	SELL	$16.97 - $25.06 $8.41 Million - $12.4 Million	-495,735 Reduced 28.96%	1,215,836 $30.5 Million
Q2 2021 Aug 16, 2021	BUY	$19.44 - $25.06 $2.86 Million - $3.69 Million	147,236 Added 9.41%	1,711,571 $33.8 Million
Q1 2021 May 17, 2021	BUY	$20.81 - $45.5 $16.8 Million - $36.8 Million	809,633 Added 107.28%	1,564,335 $36.6 Million
Q4 2020 Feb 16, 2021	BUY	$23.94 - $46.81 $12.1 Million - $23.6 Million	504,650 Added 201.82%	754,702 $29 Million
Q3 2020 Nov 10, 2020	BUY	$21.05 - $42.7 $5.26 Million - $10.7 Million	250,052 New	250,052 $6.88 Million

Others Institutions Holding ALVR

# of Institutions

Shares Held

44.6M

Call Options Held

14.9K

Put Options Held

200

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $52.1M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Allovir, Inc. Transaction History